CSTL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,439,628.73

Castle Biosciences Insider Trading History Chart

Castle Biosciences Share Price & Price History

^$28.87

▲ +0.97 (3.48%)

As of 11/19/2024 01:00 AM ET

Days: 30 | 90 | 365

31 Billionaires Are Loading Up on This Sector

From InvestorPlace | Ad

Why are 31 of the world's richest billionaires, like Warren Buffett, Jeff Bezos, the Walton family, and Bill Gates in a frenzy to ditch their stocks? And why are they all converging on ONE unique corner of the market instead?

Click here to get the details.

Castle Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/15/2024	Frank Stokes	CFO	Sell	6,923	$29.93	$207,205.39	30,823
11/12/2024	Derek J Maetzold	Insider	Sell	1,972	$34.15	$67,343.80	87,720
11/5/2024	Tobin W Juvenal	Insider	Sell	3,507	$35.56	$124,708.92	54,178
10/14/2024	Derek J Maetzold	Insider	Sell	1,972	$32.27	$63,636.44	91,664
10/8/2024	Derek J Maetzold	Insider	Sell	986	$30.27	$29,846.22	93,636
10/7/2024	Daniel Bradbury	Director	Sell	7,867	$29.44	$231,604.48	5,700
10/4/2024	Derek J Maetzold	Insider	Sell	986	$28.73	$28,327.78	94,622
8/12/2024	Daniel Bradbury	Director	Sell	7,883	$26.65	$210,081.95	8,550
8/7/2024	Frank Stokes	CFO	Sell	10,000	$25.70	$257,000.00	30,823
8/1/2024	Kristen M. Oelschlager	COO	Sell	12,989	$23.06	$299,526.34	132,836
7/29/2024	Kristen M. Oelschlager	COO	Sell	2,793	$22.06	$61,613.58	145,825
6/3/2024	Derek J Maetzold	Insider	Sell	2,368	$23.40	$55,411.20	57,893
5/6/2024	Daniel Bradbury	Director	Sell	23,323	$24.64	$574,678.72	9,981
5/6/2024	Derek J Maetzold	Insider	Sell	2,368	$24.72	$58,536.96	62,629
4/23/2024	Derek J Maetzold	Insider	Sell	421	$20.11	$8,466.31	64,997
4/12/2024	Derek J Maetzold	Insider	Sell	1,947	$20.35	$39,621.45	65,418
4/8/2024	Daniel Bradbury	Director	Sell	2,400	$20.45	$49,080.00	17,944
4/4/2024	Daniel Bradbury	Director	Sell	9,152	$21.45	$196,310.40	22,782
4/3/2024	Derek J Maetzold	Insider	Sell	2,368	$21.70	$51,385.60	67,365
3/20/2024	Derek J Maetzold	Insider	Sell	2,295	$20.27	$46,519.65	69,806
3/7/2024	Derek J Maetzold	Insider	Sell	2,372	$20.77	$49,266.44	72,101
3/5/2024	Derek J Maetzold	Insider	Sell	4,131	$21.41	$88,444.71	74,473
3/4/2024	Daniel Bradbury	Director	Sell	23,323	$20.68	$482,319.64	25,907
2/7/2024	Daniel Bradbury	Director	Sell	2,074	$23.20	$48,116.80	33,870
1/4/2024	Daniel Bradbury	Director	Sell	18,223	$20.40	$371,749.20	43,574
12/28/2023	Derek J Maetzold	Insider	Sell	3,954	$22.17	$87,660.18	64,084
12/26/2023	Derek J Maetzold	Insider	Sell	5,180	$21.93	$113,597.40	76,114
12/22/2023	Derek J Maetzold	Insider	Sell	5,224	$21.96	$114,719.04	81,294
12/20/2023	Derek J Maetzold	Insider	Sell	5,201	$21.05	$109,481.05	97,517
12/18/2023	Derek J Maetzold	Insider	Sell	5,720	$20.27	$115,944.40	108,437
12/12/2023	Daniel Bradbury	Director	Sell	1,200	$20.01	$24,012.00	50,195
12/12/2023	Derek J Maetzold	Insider	Sell	546	$20.01	$10,925.46	130,670
12/8/2023	Daniel Bradbury	Director	Sell	6,875	$20.09	$138,118.75	50,605
12/8/2023	Derek J Maetzold	Insider	Sell	2,322	$20.10	$46,672.20	94,895
12/6/2023	Daniel Bradbury	Director	Sell	200	$20.02	$4,004.00	52,952
12/6/2023	Derek J Maetzold	Insider	Sell	48	$20.02	$960.96	97,217
12/4/2023	Daniel Bradbury	Director	Sell	4,340	$20.08	$87,147.20	53,020
12/4/2023	Derek J Maetzold	Insider	Sell	1,379	$20.08	$27,690.32	97,265
12/1/2023	Daniel Bradbury	Director	Sell	9,545	$20.05	$191,377.25	54,502
12/1/2023	Derek J Maetzold	Insider	Sell	3,235	$20.06	$64,894.10	98,644
11/29/2023	Daniel Bradbury	Director	Sell	17,342	$20.12	$348,921.04	60,197
11/29/2023	Derek J Maetzold	Insider	Sell	5,743	$20.13	$115,606.59	106,389
11/24/2023	Daniel Bradbury	Director	Sell	800	$20.02	$16,016.00	63,665
11/24/2023	Derek J Maetzold	Insider	Sell	287	$20.03	$5,748.61	112,132
11/20/2023	Daniel Bradbury	Director	Sell	5,755	$20.04	$115,330.20	63,885
9/1/2023	Daniel Bradbury	Director	Sell	1,802	$20.04	$36,112.08	65,037
9/1/2023	Derek J Maetzold	Insider	Sell	718	$20.05	$14,395.90	115,103
8/30/2023	Daniel Bradbury	Director	Sell	4,632	$20.03	$92,778.96	66,854
8/30/2023	Derek J Maetzold	Insider	Sell	1,622	$20.03	$32,488.66	119,905
8/3/2023	Derek J Maetzold	Insider	Sell	286	$20.10	$5,748.60	121,527
7/7/2023	Daniel Bradbury	Director	Sell	50,000	$20.39	$1,019,500.00	67,780
7/7/2023	Derek J Maetzold	Insider	Sell	8,376	$20.04	$167,855.04	121,813
6/5/2023	Ellen Goldberg	Director	Buy	4,800	$14.38	$69,024.00	9,065
5/15/2023	Derek J Maetzold	Insider	Sell	1,538	$23.45	$36,066.10	150,443
5/4/2023	Daniel Bradbury	Director	Sell	17,643	$21.69	$382,676.67	79,251
5/4/2023	Derek J Maetzold	Insider	Sell	2,792	$21.64	$60,418.88	151,981
4/12/2023	Derek J Maetzold	Insider	Sell	969	$22.61	$21,909.09	156,596
4/5/2023	Daniel Bradbury	Director	Sell	7,100	$22.20	$157,620.00	82,780
4/3/2023	Daniel Bradbury	Director	Sell	10,300	$22.14	$228,042.00	85,720
4/3/2023	Derek J Maetzold	Insider	Sell	2,391	$22.15	$52,960.65	157,966
3/6/2023	Derek J Maetzold	Insider	Sell	2,792	$24.71	$68,990.32	163,149
3/2/2023	Daniel Bradbury	Director	Sell	11,349	$23.30	$264,431.70	90,510
1/3/2023	Daniel Bradbury	Director	Sell	7,704	$22.89	$176,344.56	199,539
1/3/2023	Derek J Maetzold	Insider	Sell	3,833	$22.90	$87,775.70	301,529
12/19/2022	Derek J Maetzold	Insider	Sell	3,833	$23.07	$88,427.31	305,362
12/5/2022	Derek J Maetzold	Insider	Sell	3,833	$24.79	$95,020.07	294,723
11/29/2022	Tiffany Olson	Director	Buy	1,162	$21.50	$24,983.00	2,968
11/21/2022	Derek J Maetzold	Insider	Sell	2,869	$20.84	$59,789.96	289,520
10/24/2022	Derek J Maetzold	Insider	Sell	3,483	$20.41	$71,088.03	296,572
10/11/2022	Derek J Maetzold	Insider	Sell	560	$24.05	$13,468.00	27,342
10/4/2022	Derek J Maetzold	Insider	Sell	541	$30.03	$16,246.23	303,889
10/3/2022	Daniel Bradbury	Director	Sell	7,704	$27.17	$209,317.68	222,651
9/26/2022	Derek J Maetzold	Insider	Sell	2,188	$23.93	$52,358.84	306,075
9/12/2022	Derek J Maetzold	Insider	Sell	2,994	$29.56	$88,502.64	309,120
8/29/2022	Derek J Maetzold	Insider	Sell	4,118	$29.56	$121,728.08	312,414
8/16/2022	Derek J Maetzold	Insider	Sell	36	$32.83	$1,181.88	28,958
8/3/2022	Derek J Maetzold	Insider	Sell	42	$30.03	$1,261.26	328,661
8/1/2022	Daniel Bradbury	Director	Sell	7,704	$27.47	$211,628.88	238,059
8/1/2022	Derek J Maetzold	Insider	Sell	3,723	$27.44	$102,159.12	328,814
5/12/2022	Tiffany Olson	Director	Buy	1,320	$18.76	$24,763.20	1,806
3/29/2022	Daniel Bradbury	Director	Sell	8,852	$45.32	$401,172.64
3/14/2022	Daniel Bradbury	Director	Sell	8,852	$38.21	$338,234.92
2/22/2022	Daniel Bradbury	Director	Sell	8,852	$39.02	$345,405.04
2/9/2022	Daniel Bradbury	Director	Sell	8,852	$46.53	$411,883.56
1/24/2022	Daniel Bradbury	Director	Sell	14,631	$35.42	$518,230.02
1/20/2022	Daniel Bradbury	Director	Sell	15,604	$35.26	$550,197.04
1/18/2022	Daniel Bradbury	Director	Sell	2,470	$35.30	$87,191.00
1/4/2022	Daniel Bradbury	Director	Sell	16,353	$43.58	$712,663.74

Trump said you could learn something from this man

From Wide Moat Research | Ad

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.

SEC Filings (Institutional Ownership Changes) for Castle Biosciences (NASDAQ:CSTL)

92.60% of Castle Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Castle Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	52,301	$1.49M	0.0%	+310.7%	0.187%
11/16/2024	Geode Capital Management LLC	624,683	$17.82M	0.0%	+1.1%	2.230%
11/15/2024	Barclays PLC	52,301	$1.49M	0.0%	+310.7%	0.187%
11/15/2024	Y Intercept Hong Kong Ltd	24,206	$0.69M	0.0%	+3.6%	0.086%
11/15/2024	Orion Portfolio Solutions LLC	72,405	$2.07M	0.0%	+16.6%	0.258%
11/15/2024	State Street Corp	680,001	$19.39M	0.0%	+9.8%	2.428%
11/15/2024	Point72 DIFC Ltd	4,895	$0.14M	0.0%	N/A	0.017%
11/15/2024	Point72 Asset Management L.P.	499,192	$14.24M	0.0%	+828.3%	1.782%
11/15/2024	Portolan Capital Management LLC	1,255,628	$35.81M	2.6%	+3.7%	4.483%
11/15/2024	Parkman Healthcare Partners LLC	296,071	$8.44M	1.1%	+6.5%	1.057%
11/15/2024	Jacobs Levy Equity Management Inc.	496,521	$14.16M	0.1%	-4.1%	1.773%
11/15/2024	Janus Henderson Group PLC	9,137	$0.26M	0.0%	N/A	0.033%
11/14/2024	Bellevue Group AG	1,262,030	$35.99M	0.6%	+3.7%	4.506%
11/14/2024	Wasatch Advisors LP	1,826,092	$52.08M	0.3%	-21.6%	6.520%
11/14/2024	Braidwell LP	331,986	$9.47M	0.3%	-20.2%	1.185%
11/14/2024	Captrust Financial Advisors	8,072	$0.23M	0.0%	-61.8%	0.029%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	55,532	$1.58M	0.0%	-1.1%	0.198%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,476	$0.27M	0.0%	-4.1%	0.034%
11/14/2024	Yu Fan	22,503	$0.64M	2.0%	-38.8%	0.080%
11/13/2024	Townsquare Capital LLC	23,270	$0.66M	0.0%	+25.2%	0.083%
11/13/2024	Advantage Alpha Capital Partners LP	10,940	$0.31M	0.1%	N/A	0.039%
11/13/2024	Dynamic Technology Lab Private Ltd	43,894	$1.25M	0.1%	N/A	0.157%
11/12/2024	Alpha DNA Investment Management LLC	16,763	$0.48M	0.2%	-16.3%	0.060%
11/12/2024	Algert Global LLC	134,321	$3.83M	0.1%	+0.4%	0.480%
11/12/2024	Charles Schwab Investment Management Inc.	274,761	$7.84M	0.0%	+16.7%	0.981%
11/9/2024	Intech Investment Management LLC	8,284	$0.24M	0.0%	N/A	0.030%
11/8/2024	First Horizon Advisors Inc.	2,070	$59K	0.0%	-73.6%	0.007%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	165,458	$4.72M	0.0%	+147.4%	0.599%
11/7/2024	Quest Partners LLC	4,318	$0.12M	0.0%	+54.4%	0.016%
11/7/2024	Thrivent Financial for Lutherans	23,290	$0.66M	0.0%	+58.0%	0.084%
11/5/2024	GSA Capital Partners LLP	51,827	$1.48M	0.1%	N/A	0.188%
11/4/2024	Lisanti Capital Growth LLC	154,710	$4.41M	1.1%	+60.2%	0.560%
11/1/2024	Assetmark Inc.	5,212	$0.15M	0.0%	+16.8%	0.019%
11/1/2024	Summit Global Investments	30,441	$0.87M	0.1%	+27.8%	0.110%
10/31/2024	Kornitzer Capital Management Inc. KS	407,238	$11.61M	0.2%	-25.0%	1.475%
10/31/2024	Principal Financial Group Inc.	1,538,520	$43.88M	0.0%	+2.7%	5.573%
10/31/2024	Perkins Capital Management Inc.	32,640	$0.93M	0.9%	+5.0%	0.118%
10/29/2024	Harbor Capital Advisors Inc.	153,907	$4.39M	0.2%	+11.0%	0.557%
10/28/2024	Stephens Inc. AR	15,095	$0.43M	0.0%	-36.5%	0.055%
10/28/2024	US Bancorp DE	4,615	$0.13M	0.0%	+1,889.2%	0.017%
10/25/2024	Diversify Wealth Management LLC	13,398	$0.38M	0.0%	-9.2%	0.049%
10/25/2024	China Universal Asset Management Co. Ltd.	5,335	$0.15M	0.0%	+64.6%	0.019%
10/24/2024	First Bank & Trust	9,164	$0.26M	0.0%	N/A	0.033%
10/19/2024	Allspring Global Investments Holdings LLC	10,010	$0.29M	0.0%	-6.9%	0.036%
10/11/2024	Creative Planning	10,472	$0.30M	0.0%	N/A	0.038%
10/10/2024	Inspire Investing LLC	42,516	$1.21M	0.1%	+14.4%	0.154%
10/3/2024	SG Americas Securities LLC	7,659	$0.22M	0.0%	-71.6%	0.028%
8/21/2024	Truist Financial Corp	14,217	$0.31M	0.0%	+20.5%	0.051%
8/19/2024	Point72 Asset Management L.P.	53,777	$1.17M	0.0%	N/A	0.195%
8/16/2024	Algert Global LLC	133,722	$2.91M	0.1%	-8.0%	0.484%
8/15/2024	The Manufacturers Life Insurance Company	10,122	$0.22M	0.0%	+7.1%	0.037%
8/15/2024	Deerfield Management Company L.P. Series C	874,609	$19.04M	0.3%	-5.8%	3.168%
8/15/2024	Alpha DNA Investment Management LLC	20,038	$0.44M	0.2%	-13.0%	0.073%
8/14/2024	Cubist Systematic Strategies LLC	92,475	$2.01M	0.0%	+13.1%	0.335%
8/14/2024	Marshall Wace LLP	212,036	$4.62M	0.0%	+116.5%	0.768%
8/14/2024	ABG Innovation Capital Partners III GP Ltd	36,747	$0.80M	93.0%	+9.3%	0.133%
8/14/2024	Yu Fan	36,747	$0.80M	1.0%	-95.0%	0.133%
8/12/2024	Inspire Investing LLC	37,167	$0.81M	0.1%	N/A	0.135%
8/12/2024	XTX Topco Ltd	10,003	$0.22M	0.0%	N/A	0.036%
8/12/2024	Hsbc Holdings PLC	33,852	$0.71M	0.0%	-1.8%	0.123%
8/9/2024	Renaissance Technologies LLC	301,500	$6.56M	0.0%	+47.3%	1.092%
8/9/2024	Dimensional Fund Advisors LP	809,934	$17.63M	0.0%	+8.1%	2.934%
8/8/2024	American Century Companies Inc.	42,818	$0.93M	0.0%	+12.9%	0.155%
8/6/2024	Quest Partners LLC	2,796	$61K	0.0%	-30.6%	0.010%
8/6/2024	Acadian Asset Management LLC	280,497	$6.10M	0.0%	+33.0%	1.016%
8/2/2024	Simon Quick Advisors LLC	23,608	$0.51M	0.0%	-18.8%	0.086%
8/1/2024	Rhumbline Advisers	41,896	$0.91M	0.0%	+7.7%	0.152%
8/1/2024	Lisanti Capital Growth LLC	96,550	$2.10M	0.5%	N/A	0.350%
7/29/2024	Principal Financial Group Inc.	1,498,143	$32.61M	0.0%	-2.2%	5.426%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,882	$0.22M	0.0%	+10.7%	0.036%
7/26/2024	Legato Capital Management LLC	14,155	$0.31M	0.0%	N/A	0.051%
7/26/2024	Bank of New York Mellon Corp	96,688	$2.11M	0.0%	+15.0%	0.350%
7/22/2024	Summit Global Investments	23,812	$0.52M	0.0%	N/A	0.086%
7/12/2024	SG Americas Securities LLC	26,989	$0.59M	0.0%	N/A	0.098%
7/9/2024	Harbor Capital Advisors Inc.	138,707	$3.02M	0.2%	+249.3%	0.502%
5/16/2024	California State Teachers Retirement System	25,484	$0.56M	0.0%	-4.8%	0.092%
5/16/2024	Invenomic Capital Management LP	166,714	$3.69M	0.2%	-3.0%	0.604%
5/16/2024	Jacobs Levy Equity Management Inc.	531,902	$11.78M	0.1%	-0.9%	1.927%
5/15/2024	Public Employees Retirement System of Ohio	93,436	$2.07M	0.0%	-6.8%	0.338%
5/15/2024	Bellevue Group AG	1,220,085	$27.03M	0.4%	-1.0%	4.419%
5/15/2024	Price T Rowe Associates Inc. MD	18,034	$0.40M	0.0%	+6.7%	0.065%
5/10/2024	Acadian Asset Management LLC	210,824	$4.67M	0.0%	+130.7%	0.764%
5/10/2024	Vanguard Group Inc.	1,494,176	$33.10M	0.0%	+2.2%	5.412%
5/9/2024	Orion Portfolio Solutions LLC	67,237	$1.49M	0.0%	-3.6%	0.244%
5/9/2024	State Board of Administration of Florida Retirement System	10,954	$0.25M	0.0%	N/A	0.040%
5/3/2024	GSA Capital Partners LLP	52,448	$1.16M	0.1%	+9.0%	0.191%
5/3/2024	RiverPark Advisors LLC	2,861	$63K	0.1%	+362.2%	0.010%
5/1/2024	Diversify Advisory Services LLC	12,498	$0.28M	0.0%	N/A	0.046%
4/30/2024	Norden Group LLC	24,673	$0.55M	0.0%	N/A	0.090%
4/30/2024	Allspring Global Investments Holdings LLC	10,862	$0.24M	0.0%	+89.3%	0.040%
4/29/2024	Principal Financial Group Inc.	1,532,472	$33.94M	0.0%	-3.4%	5.583%
4/29/2024	China Universal Asset Management Co. Ltd.	5,297	$0.12M	0.0%	+70.3%	0.019%
4/26/2024	Tritonpoint Wealth LLC	92,250	$2.04M	0.2%	-2.2%	0.336%
4/19/2024	Norden Group LLC	24,673	$0.55M	0.0%	N/A	0.090%
4/19/2024	Denali Advisors LLC	8,400	$0.19M	0.1%	N/A	0.031%
4/18/2024	Wasatch Advisors LP	2,551,088	$56.51M	0.3%	-1.5%	9.294%
4/18/2024	Allspring Global Investments Holdings LLC	10,862	$0.24M	0.0%	+89.3%	0.040%
2/15/2024	Parkman Healthcare Partners LLC	357,156	$7.71M	1.1%	+59.0%	1.327%
2/15/2024	Granahan Investment Management LLC	2,166,471	$46.75M	1.5%	-12.9%	8.051%
2/15/2024	Birchview Capital LP	10,000	$0.22M	0.2%	N/A	0.037%

Data available starting January 2016

Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

Today's Range

Now: $28.87

$27.24

$29.02

50 Day Range

MA: $31.10

$27.86

$34.67

52 Week Range

Now: $28.87

$16.97

$35.84

Volume

347,085 shs

Average Volume

327,574 shs

Market Capitalization

$808.65 million

P/E Ratio

144.36

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Castle Biosciences?: Castle Biosciences' top insider shareholders include:
Derek J Maetzold (Insider)
Daniel Bradbury (Director)
Kristen M Oelschlager (COO)
Tobin W Juvenal (Insider)
Frank Stokes (CFO)
Ellen Goldberg (Director)
Tiffany Olson (Director)
Learn More about top insider investors at Castle Biosciences.
Who are the major institutional investors of Castle Biosciences?: Castle Biosciences' top institutional shareholders include:
Wasatch Advisors LP — 6.52%
Principal Financial Group Inc. — 5.57%
Bellevue Group AG — 4.51%
Portolan Capital Management LLC — 4.48%
State Street Corp — 2.43%
Geode Capital Management LLC — 2.23%
Learn More about top institutional investors of Castle Biosciences stock.
Which major investors are selling Castle Biosciences stock?: During the last quarter, CSTL stock was sold by these institutional investors:
Wasatch Advisors LP
Kornitzer Capital Management Inc. KS
Braidwell LP
Jacobs Levy Equity Management Inc.
SG Americas Securities LLC
Yu Fan
Captrust Financial Advisors
Stephens Inc. AR
During the previous year, company insiders that have sold Castle Biosciences company stock include:
Derek J Maetzold (Insider)
Daniel Bradbury (Director)
Kristen M Oelschlager (COO)
Tobin W Juvenal (Insider)
Frank Stokes (CFO)
Learn More investors selling Castle Biosciences stock.
Which major investors are buying Castle Biosciences stock?: During the last quarter, CSTL stock was purchased by institutional investors including:
Point72 Asset Management L.P.
Connor Clark & Lunn Investment Management Ltd.
State Street Corp
Lisanti Capital Growth LLC
GSA Capital Partners LLP
Bellevue Group AG
Portolan Capital Management LLC
Dynamic Technology Lab Private Ltd
In the previous year, these company insiders have bought Castle Biosciences stock:
Derek J Maetzold (Insider)
Daniel Bradbury (Director)
Learn More investors buying Castle Biosciences stock.